Billionaire Lee Ainslie’s 5 Stocks with Huge Upside Potential

Page 1 of 5

In this article, we will list the Billionaire Lee Ainslie’s 5 Stocks with Huge Upside Potential. Please visit Billionaire Lee Ainslie’s 10 Stocks with Huge Upside Potential if you would like to see the extended list and the methodology behind it.

5. Wave Life Sciences Ltd (NASDAQ:WVE)

Maverick Capital Equity Stake: $73.67 Million

Number of Hedge Fund Holders: 42

Stock Upside Potential: 269.24%

Wave Life Sciences Ltd (NASDAQ:WVE) is one of billionaire Lee Ainslie’s stocks with huge upside potential. Analysts expect Wave Life Sciences shares to explode by almost 270% over the next 12 months.

On May 20, Wells Fargo raised its price target on Wave Life Sciences shares to $14 from $13 while keeping an Overweight rating on the stock. For this action, Wells Fargo cited updated data from the company’s AATD program WVE-006.

Billionaire Lee Ainslie's 5 Stocks with Huge Upside Potential

Photo by AlphaTradeZone on Pexels

Wave Life Sciences Ltd (NASDAQ:WVE) reported updated data from the ongoing RestorAATion-2 trial of WVE-006 on May 18. The company said the data affirm WVE-006’s potential to address both lung and liver AATD with convenient, safe, and durable therapy.

According to Wave Life Sciences, the only approved treatment for AATD addresses only lung disease, while there is no approved treatment for AATD liver disease. The company said it was on track for feedback from the FDA on a potential accelerated pathway for WVE-006 in mid-2026.

Wave’s RestorAATion-2 trial of WVE-006 includes both single ascending dose and multiple ascending dose portions. Wells Fargo noted that the 600mg single-ascending dose showed improved results and that the 600mg multiple-ascending dose could deliver better efficacy.

Wave Life Sciences Ltd (NASDAQ:WVE) is a biotechnology company based in Massachusetts. The company is developing RNA medicines for a wide range of health conditions. Its pipeline includes clinical programs targeting obesity, alpha-1 antitrypsin deficiency, liver disease, Duchenne muscular dystrophy, and Huntington’s disease.

Page 1 of 5
1281292 - 11759070 - 1